Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.

Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I; CHARTER Group; HNRC Group.

J Neurovirol. 2011 Feb;17(1):3-16. doi: 10.1007/s13365-010-0006-1. Epub 2010 Dec 21.

2.

Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline.

Comi C, Carecchio M, Chiocchetti A, Nicola S, Galimberti D, Fenoglio C, Cappellano G, Monaco F, Scarpini E, Dianzani U.

J Alzheimers Dis. 2010;19(4):1143-8. doi: 10.3233/JAD-2010-1309.

PMID:
20308780
3.

Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy.

Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, Moore D, Ellis R, Cherner M, Gelman B, Morgello S, Singer E, Grant I, Masliah E; National NeuroAIDS Tissue Consortium (NNTC).

J Neurovirol. 2009 Sep;15(5-6):360-70. doi: 10.3109/13550280903131915.

4.

HIV-1 neuroimmunity in the era of antiretroviral therapy.

Kraft-Terry SD, Stothert AR, Buch S, Gendelman HE.

Neurobiol Dis. 2010 Mar;37(3):542-8. doi: 10.1016/j.nbd.2009.12.015. Epub 2010 Jan 4. Review.

5.

Leukocyte transmigration across the blood-brain barrier: perspectives on neuroAIDS.

Roberts TK, Buckner CM, Berman JW.

Front Biosci (Landmark Ed). 2010 Jan 1;15:478-536. Review.

PMID:
20036831
6.

Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.

Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave JP, Giacobini E, Hirschel B, Du Pasquier RA.

AIDS. 2010 Jun 1;24(9):1243-50. doi: 10.1097/QAD.0b013e3283354a7b.

PMID:
19996937
7.

Neuronal expression of Cd36, Cd44, and Cd83 antigen transcripts maps to distinct and specific murine brain circuits.

Glezer I, Bittencourt JC, Rivest S.

J Comp Neurol. 2009 Dec 20;517(6):906-24. doi: 10.1002/cne.22185.

PMID:
19844997
8.
9.

New dual monoclonal ELISA for measuring plasma osteopontin as a biomarker associated with survival in prostate cancer: clinical validation and comparison of multiple ELISAs.

Anborgh PH, Wilson SM, Tuck AB, Winquist E, Schmidt N, Hart R, Kon S, Maeda M, Uede T, Stitt LW, Chambers AF.

Clin Chem. 2009 May;55(5):895-903. doi: 10.1373/clinchem.2008.117465. Epub 2009 Mar 26.

10.

Low atazanavir concentrations in cerebrospinal fluid.

Best BM, Letendre SL, Brigid E, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Ellis R, Capparelli EV, Grant I; CHARTER Group.

AIDS. 2009 Jan 2;23(1):83-7. doi: 10.1097/QAD.0b013e328317a702.

11.

Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies.

Fischer-Smith T, Bell C, Croul S, Lewis M, Rappaport J.

J Neurovirol. 2008 Aug;14(4):318-26. doi: 10.1080/13550280802132857. Review.

12.

Osteopontin is increased in HIV-associated dementia.

Burdo TH, Ellis RJ, Fox HS.

J Infect Dis. 2008 Sep 1;198(5):715-22. doi: 10.1086/590504.

13.

Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.

Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, Wurcel A, Zaman T, Stone D, Mefford M, Morgello S, Singer EJ, Wolinsky SM, Gabuzda D.

PLoS One. 2008 Jun 25;3(6):e2516. doi: 10.1371/journal.pone.0002516.

14.

Increased expression of monocyte CD44v6 correlates with the deveopment of encephalitis in rhesus macaques infected with simian immunodeficiency virus.

Marcondes MC, Lanigan CM, Burdo TH, Watry DD, Fox HS.

J Infect Dis. 2008 Jun 1;197(11):1567-76. doi: 10.1086/588002.

15.

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ; CHARTER Group.

Arch Neurol. 2008 Jan;65(1):65-70. doi: 10.1001/archneurol.2007.31.

16.

Quantitative imaging assay for NF-kappaB nuclear translocation in primary human macrophages.

Noursadeghi M, Tsang J, Haustein T, Miller RF, Chain BM, Katz DR.

J Immunol Methods. 2008 Jan 1;329(1-2):194-200. Epub 2007 Nov 20.

17.

Osteopontin small interfering RNA protects mice from fulminant hepatitis.

Saito Y, Kon S, Fujiwara Y, Nakayama Y, Kurotaki D, Fukuda N, Kimura C, Kanayama M, Ito K, Diao H, Matsui Y, Komatsu Y, Ohtsuka E, Uede T.

Hum Gene Ther. 2007 Dec;18(12):1205-14.

PMID:
17988193
18.

Osteopontin prevents monocyte recirculation and apoptosis.

Burdo TH, Wood MR, Fox HS.

J Leukoc Biol. 2007 Jun;81(6):1504-11. Epub 2007 Mar 16.

19.

Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain.

Wung JK, Perry G, Kowalski A, Harris PL, Bishop GM, Trivedi MA, Johnson SC, Smith MA, Denhardt DT, Atwood CS.

Curr Alzheimer Res. 2007 Feb;4(1):67-72.

PMID:
17316167
20.

Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model.

Maetzler W, Berg D, Schalamberidze N, Melms A, Schott K, Mueller JC, Liaw L, Gasser T, Nitsch C.

Neurobiol Dis. 2007 Mar;25(3):473-82. Epub 2006 Dec 26.

PMID:
17188882

Supplemental Content

Support Center